Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy.
Hansen, J B
Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy. [electronic resource] - Thrombosis research Aug 1998 - 177-81 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0049-3848
10.1016/s0049-3848(98)00079-6 doi
Administration, Cutaneous
Adult
Anticoagulants--administration & dosage
Antithrombins--metabolism
Heparin--administration & dosage
Heparin, Low-Molecular-Weight--administration & dosage
Humans
Infusions, Intravenous
Lipoproteins--blood
Male
Protein C--metabolism
Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy. [electronic resource] - Thrombosis research Aug 1998 - 177-81 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0049-3848
10.1016/s0049-3848(98)00079-6 doi
Administration, Cutaneous
Adult
Anticoagulants--administration & dosage
Antithrombins--metabolism
Heparin--administration & dosage
Heparin, Low-Molecular-Weight--administration & dosage
Humans
Infusions, Intravenous
Lipoproteins--blood
Male
Protein C--metabolism